The use of the X-Sizer™ transluminal extraction catheter as an adjunct to stenting of occluded saphenous vein grafts

Journal of Invasive Cardiology

Volumn 15, Issue 5, 2003, Pages 293-296

  Strike, Philip C ^a   Robinson, Nicholas M ^b   Dymond, Duncan S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; CATHETER; DEVICE; FEMALE; GRAFT OCCLUSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; SAPHENOUS VEIN GRAFT; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; BLOOD VESSEL TRANSPLANTATION; INDWELLING CATHETER; INSTRUMENTATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOGRAPHY; SAPHENOUS VEIN; TRANSPLANTATION;

AGED; ANTIBODIES, MONOCLONAL; ASPIRIN; BLOOD VESSEL PROSTHESIS IMPLANTATION; CATHETERS, INDWELLING; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SAPHENOUS VEIN; STENTS; TICLOPIDINE;

EID: 0038288923     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous De Novo Trial Investigators. N Engl J Med 1997;337:740-747.
2. Platko WP, Hollman J, Whitlow PL, Franc I. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: Long-term follow up. J Am Coll Cardiol 1989;14:1645-1650.
3. Cote G, Myler RK, Stertzer SH, et al. Percutaneous transluminal angioplasty of coronary artery bypass grafts: 5 years' experience. J Am Coll Cardiol 1987;9:8-17.
4. Douglas JS Jr., Gruentzig AR, King SB 3rd, et al. Percutaneous transluminal angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol 1983;2:745-754.
5. Tan KH, Henderson RA, Sulke N, et al. Percutaneous transluminal angioplasty in patients with prior coronary artery grafting: Ten years' experience. Cathet Cardiovasc Diagn 1994;32:11-17.
6. Waksman R, Weintaub WS, Ghazzal Z, et al. Short and long-term outcome of narrowed saphenous vein bypass graft: A comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. Am Heart J 1997;134:274-281.
7. Brener SJ, Ellis SG, Apperson-Hansen C, et al. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol 1997;79:13-18.
8. Fenton SH, Fischman DL, Savage RA, et al. Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. Am J Cardiol 1994;74:1187-1191.
9. Meany TB, Leon MB, Kramer BL, et al. Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: A multicentre experience. Cathet Cardiovasc Diagn 1995;34:112-120.
10. Piana RN, Mosucci M, Cohen DJ, et al. Palmaz-Schatz stenting for the treatment of focal vein graft stenosis: Immediate results and long-term outcome. J Am Coll Cardiol 1994;23:1296-1304.
11. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. JAm Coll Cardiol 1995;26:704-712.
12. Holmes DR, Berger PB. Percutaneous revascularisation of occluded vein grafts: Is it still a temptation to be resisted? Circulation 1999;99:8-11.
13. Hartmann JR, McKeevor LS, O Neill WW, et al. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term low dose direct infusion of urokinase (ROBUST): A serial trial. J Am Coll Cardiol 1996;27:60-66.
14. Mooney MR, Mooney JF, Goldenburg JF, et al. Percutaneous transluminal coronary angioplasty in the setting of large intracoronary thrombi. Am J Cardiol 1990;65:427-431.
15. Mattos LA, Sousa AG, Campos Neto CD, et al. The use of primary stenting or balloon percutaneous transluminal coronary angioplasty for the treatment of acutely occluded saphenous vein grafts. Results from the Brazilian National Registry - CENIC Arq Bras Cardiol 2001;76:490-495.
16. Carlino M, De Gregario J, Di Mario C, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 1999;99:3221-3223.
17. Lefkovits J, Holmes DR, Califf RM, et al. Predictors and sequelae of distal embolization during saphenous vein intervention from the CAVEAT II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation 1995;92:734-740.
18. Strauss BH, Natarajan MK, Batchelor WB, et al. Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty. Circulation 1995;92:348-356.
19. Shaknovich A, Forman ST, Parikh MA, et al. Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts. Cathet Cardiovasc Intervent 1999;47:397-403.
20. Baldus S, Koster R, Elsner M. Treatment of aortocoronary vein graft lesions with membrane-covered stents: A multicentre surveillance trial. Circulation 2000;102:2024-2027.
21. Robinson N, Barakat K, Dymond D. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus. Heart 1999;81:434-437.
22. Barsness GW, Buller C, Schechter E, et al. Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. Am Heart J 2000;139:824-829.
23. Khan MA, Liu MW, Chio FL, et al. Effect of abciximab on cardiac enzyme elevation after transluminal extraction atherectomy (TEC) in high risk saphenous vein graft lesions: Comparison with a historical control group. Cathet Cardiovasc Intervent 2001;52:40-44.
24. Mak KH, Challapalli, Eisenberg MJ, for the EPIC Investigators. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol 1997;80:985-988.
25. Sullebarger JT, Dalton RD, Nasser A, Matar FA. Adjunctive abciximab improves outcomes during recanalization of totally occluded saphenous vein grafts using transluminal extraction atherectomy. Cathet Cardiovasc Intervent 1999;46:107-110.
26. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001;38:150-154.